Approved Hospital Formulary
Add Formweb to your mobile device
Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Please be sure to document all clinical activities daily.
Approved Hospital Formulary
Search results for:
omalizumab
omalizumab
- Restricted Xolair --> Restricted to Outpatient
- Restricted Miscellaneous Program Formulary
- Therapeutic Interchange
VIEW MORE Respiratory Tract Agents, Miscellaneous
Last updated: Sep. 10, 2025
- Black Box Warning: Anaphylaxis
Xolair medication guide
Xolair and all biosimilars reviewed by the Committee are classified as therapeutically equivalent and interchangeable and formulary, restricted to the hospital outpatient setting. The most cost-effective product will be used for a specific patient, setting, or time period.
Inpatients should use home supply.
For Updated Formulary Preferred Products (Inpatient and Outpatient): Preferred Products for Select Agents
Reviewed: August 2025
Omalizumab-igec (OMLYCLO) Spotlight.pdf